184 related articles for article (PubMed ID: 32482711)
1. HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.
Osterbye T; Nielsen M; Dudek NL; Ramarathinam SH; Purcell AW; Schafer-Nielsen C; Buus S
J Immunol; 2020 Jul; 205(1):290-299. PubMed ID: 32482711
[TBL] [Abstract][Full Text] [Related]
2. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.
Gaseitsiwe S; Valentini D; Mahdavifar S; Reilly M; Ehrnst A; Maeurer M
Clin Vaccine Immunol; 2010 Jan; 17(1):168-75. PubMed ID: 19864486
[TBL] [Abstract][Full Text] [Related]
3. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
Oyarzún P; Ellis JJ; Bodén M; Kobe B
BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
[TBL] [Abstract][Full Text] [Related]
4. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.
Lin HH; Zhang GL; Tongchusak S; Reinherz EL; Brusic V
BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S22. PubMed ID: 19091022
[TBL] [Abstract][Full Text] [Related]
6. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
7. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
Front Immunol; 2020; 11():1705. PubMed ID: 32903714
[TBL] [Abstract][Full Text] [Related]
8. An empirical method for the prediction of T-cell epitopes.
Davenport MP; Ho Shon IA; Hill AV
Immunogenetics; 1995; 42(5):392-7. PubMed ID: 7590973
[TBL] [Abstract][Full Text] [Related]
9. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
10. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens.
Novak EJ; Liu AW; Gebe JA; Falk BA; Nepom GT; Koelle DM; Kwok WW
J Immunol; 2001 Jun; 166(11):6665-70. PubMed ID: 11359821
[TBL] [Abstract][Full Text] [Related]
11. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
Bordner AJ; Mittelmann HD
BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
[TBL] [Abstract][Full Text] [Related]
12. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
13. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
14. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
15. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
[TBL] [Abstract][Full Text] [Related]
16. Interaction profiling of T-cell epitopes with MHC-class I molecules.
Dash BP; Mukherjee S; Suhas VL; Chandra N
Protein Pept Lett; 2007; 14(6):557-64. PubMed ID: 17627596
[TBL] [Abstract][Full Text] [Related]
17. The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse model.
Hill JA; Wang D; Jevnikar AM; Cairns E; Bell DA
Arthritis Res Ther; 2003; 5(1):R40-8. PubMed ID: 12716452
[TBL] [Abstract][Full Text] [Related]
18. Defining MHC class II T helper epitopes for WT1 tumor antigen.
Kobayashi H; Nagato T; Aoki N; Sato K; Kimura S; Tateno M; Celis E
Cancer Immunol Immunother; 2006 Jul; 55(7):850-60. PubMed ID: 16220325
[TBL] [Abstract][Full Text] [Related]
19. Improved methods for predicting peptide binding affinity to MHC class II molecules.
Jensen KK; Andreatta M; Marcatili P; Buus S; Greenbaum JA; Yan Z; Sette A; Peters B; Nielsen M
Immunology; 2018 Jul; 154(3):394-406. PubMed ID: 29315598
[TBL] [Abstract][Full Text] [Related]
20. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
